David Krempa

Insider Reports History

Entity
Individual
Location
29125 W Field Parkway, Suite 235, Deer Park, IL
Signature
/s/ David Krempa
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Krempa:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eton Pharmaceuticals, Inc. Chief Business Officer Restricted Stock Units 861K $4.09M $4.75 Oct 2, 2024 Direct
Eton Pharmaceuticals, Inc. Chief Business Officer Stock Option (Right to buy) 813K Feb 13, 2024 Direct

Insider Reports Filed by David Krempa

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ETON Eton Pharmaceuticals, Inc. Oct 2, 2024 1 $0 4 Oct 4, 2024 Chief Business Officer
ETON Eton Pharmaceuticals, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Chief Business Officer
ETON Eton Pharmaceuticals, Inc. Mar 1, 2023 0 $0 3 Mar 8, 2023 Chief Business Officer